Home
About
Overview
Sharing Data
ORCID
Help
History (36)
When physicians forego the doctor-patient relationship, should they elect to self-prescribe or curbside? An empirical and ethical analysis.
Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Role of T cell-nuclear factor ?B in transplantation.
Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and gender.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
See All 36 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma. N Engl J Med. 2022 11 03; 387(18):1649-1660.
View in:
PubMed
subject areas
Adolescent
Adult
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Child
Cyclophosphamide
Doxorubicin
Etoposide
Hodgkin Disease
Humans
Neoplasm Recurrence, Local
Prednisone
Treatment Outcome
Vincristine